2nd International Congress Clinically Relevant Drug
(16.02.2011, Pharma-Zeitung.de)
Recent FDA regulations and the EMA’s guideline on the
investigation of drug interactions, as well as the ITC whitepaper are setting new challenges for pharmaceutical companies dealing with drug transporters and drug metabolism and pharmacokinetics (DMPK).
IQPC’s International Congress Clinically Relevant DrugTransporters
from 12 - 14 April, 2011 in Berlin, Germany,
will bring together pharmaceutical and academic scientists to discuss the current issues affecting drug transporters research and development.
Main areas of discussions will be:
• Effective testing and modelling methodology
• In vitro-to-in vivo and preclinical-to-clinical translation of transport data
• Impact of regulatory authorities and the ITC whitepaper
• The impact of membrane transporters on drug development programmes
On 12 and 13 April, delegates will hear case studies from leading companies and institutions in the field of drug transporters such as Sanofi-Aventis Deutschland GmbH, Johnson & Johnson, Belgium, the University of Toronto, Canada and the University of Tokyo, Japan.
During the Interactive Workshop Day on 14 April, delegates can enhance their knowledge of
topics such as:
• Neurovascular unit and biochemical barrier function
• Modelling of transporter driven DDI
• Model-based drug development: Incorporating population variability into mechanistic
prediction of PK and modelling of PK-PD
• Species differences in drug transport and drug metabolism - do we have good enough
experimental models to work with?
Further information, including the full conference program and additional content downloads, are available on www.drug-transporters.com/PR.
Über IQPC GMBH
IQPC GmbH
Friedrichstr. 94, D-10117 Berlin, Germany t: +49 (0) 30 2091 3330 | f: +49 (0) 30 2091 3263 | e: info@iqpc.de | w: www.iqpc.de
About IQPC:
IQPC has offices in major cities across six continents including: Berlin, Dubai, London, New York, Sao Paulo, Singapore, Johannesburg, Sydney and Toronto. IQPC leverages a global research base of best practices to produce an unrivaled portfolio of problem-solving conferences. Each year IQPC offers approximately 2,000 worldwide conferences, seminars, and related learning programs.
Weitere Informationen anfordern
Kontaktieren Sie den Autor um weitere Informationen zu erhalten. Füllen Sie das folgende Formular aus und erhalten Sie kostenfrei und unverbindlich weitere Informationen vom Anbieter.
Weitere Pressemitteilungen von IQPC GMBH
